Skip to main content

Stopping Glioblastoma Brain Tumors in their Path

  • Synopsis: Published: 2014-01-09 - Study by Montreal Neurological Institute and Hospital sheds new information on Glioblastoma (GBM) the most common and deadly form of brain cancer - McGill University (Anita Kar - anita.kar@mcgill.ca - 514-398-3376).

Main Document

Quote: "We wanted to find out how GBM-derived BTICs are able to initiate a tumor with the ultimate goal of preventing the re-growth of this deadly form of brain cancer"

New study sheds light on most common and deadly form of brain cancer.

Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumors and occurring mostly in adults between the ages of 45 and 70. The aggressive recurrent nature of this cancer is only temporarily contained by combined surgery, chemotherapy and radiation treatment. The recurrence of GBM is usually fatal, resulting in an average patient survival time of less than two years. A new study from the Montreal Neurological Institute and Hospital - The Neuro - at McGill University, published in Nature Communications , identifies two specific key players in the growth of GBM.

A GBM tumor contains a complex combination of different cell types, including 'stem-like' cells that are able to initiate brain tumor growth, even when present in very small numbers. These cells, known as brain-tumor initiating cells (BTICs), are believed to be among the cells that can re-initiate GBM if they are not completely eradicated through surgery, radiation and chemotherapy. Thus, BTICs represent an important therapeutic target for GBM treatment strategies.

"We wanted to find out how GBM-derived BTICs are able to initiate a tumor with the ultimate goal of preventing the re-growth of this deadly form of brain cancer," says Dr. Stefano Stifani, neuroscientist at The Neuro and senior investigator on the paper. "What we found is that by impairing the activity of two transcription factors (proteins that control gene expression), termed FOXG1 and TLE, we can significantly reduce the ability of BTICs to give rise to brain tumors."

The researchers studied brain tumor growth in an in vivo mouse model using human GBM-derived BTICs. This approach provides what is called an in vivo environment that closely resembles the original human brain tumors. The demonstration that the FOXG1 and TLE proteins are important for the tumor-forming ability of human GBM-derived BTICs has long-term implications because FOXG1 and TLE control the expression of numerous genes. Identifying the genes whose expression is controlled by FOXG1 and TLE is expected to provide further information on the mechanisms involved in GBM tumourigenesis. In the long term, researchers hope to identify multiple important regulators, in order to find new potential therapeutic targets to impair the tumourigenic ability of BTICs.

"The implication of transcription factors FOXG1 and TLE in the tumor-forming ability of BTICs opens the door to possible strategies to block tumor growth - a major advance in the fight against GBM."

The Neuro's Brain Tumor Program sees 3500 patients annually, and performs on average 450 tumor procedures per year. These procedures include surgeries for brain cancers such as GBM and other gliomas, as well as meningiomas, vestibular schwannomas, pituitary adenomas, metastases, among others.

This research, which was supported by the Canadian Institutes of Health Research and the Cancer Research Society, highlights the benefits of The Neuro's integrated model - where clinicians collaborate closely with researchers, to significantly advance neuroscience and clinical care for patients with neurological disease.

Related Information:

  1. Cedars-Sinai Medical Center (Nov 25, 2013). Glioblastoma Multiforme Brain Cancer Study Shows 50% of Patients Alive After 5 Years
    https://www.disabled-world.com/health/cancer/brain/gm.php
  2. Inderscience Publishers (Jul 07, 2011). What Causes Glioblastoma Brain Cancer
    https://www.disabled-world.com/health/cancer/brain/glioblastoma.php
  3. University of North Carolina School of Medicine (Apr 10, 2009). Chemical Compound may Stop Brain Tumors
    https://www.disabled-world.com/health/cancer/brain/stop-brain-tumor.php


Information from our Brain Cancer & Tumors: Types & Information section - (Full List).

Submit event details, disability news, and assistive technology products for publishing on Disabled World


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be. Also see information on blood group types and compatibility.



  1. Social Networking Helps Keep People Healthy
  2. Majority in Favor of Spinal Muscular Atrophy (SMA) Screening
  3. When the Spinal Cord Takes Charge of Information Related to Movement
  4. Sign Language Comparative List of Astronomical Words




Citation



Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.

Disclaimer: Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.